<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2897923/" ref="ordinalpos=1400&amp;ncbi_uid=3186731&amp;link_uid=PMC2897923" image-link="/pmc/articles/PMC2897923/figure/F2/" class="imagepopup">Figure 2. The Wnt/PCP <span class="highlight" style="background-color:">Signaling</span> <span class="highlight" style="background-color:">Pathway</span> and Points of Intervention.  From: Striking the Target in Wnt-y Conditions: Intervening in Wnt <span class="highlight" style="background-color:">Signaling</span> During Cancer Progression. </a></div><br /><div class="p4l_captionBody">Receptor activation by Wnt leads to the recruitment of Dsv, resulting in the activation of Rac1 and RhoA, both of which are involved in cytoskeletton remodeling and establishment of an EMT phenotype.</div></div>